Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

 

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
S

SOHO 2021 Debate on Old Prognostic Markers in CLL Management: Do They Still Have a Role?

By Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021) FEATURING Steven Coutre
By Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021) FEATURING Steven Coutre
2 views
September 30, 2021
0 Comments
Login to view comments. Click here to Login
Leukemia
13:29
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Next Questions in ALL

Feat. B. Shah
09:45
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Next Questions in AML

Feat. H. Kantarjian
10:37
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Next Questions in CLL

Feat. S. O'Brien
11:49
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Next Questions in CML

Feat. J. Cortés
16:18
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Managing TKI Resistance in CML: New Options

Feat. D. Rea
16:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update: State-of-the-Art in CML

Feat. A. Hochhaus
16:33
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on CML and Pregnancy

Feat. E. Abruzzese
11:12
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 OPTIC Primary Analysis on CP-CML: A Dose-Optimization Stud…

Feat. J. Cortés
14:51
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Treatment-Free Remission in CML

Feat. E. Atallah
21:57
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Case Study: Managing Cytopenias on TKI Therapy in CML

Feat. J. Apperley
18:11
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on the Use of MRD in CLL: American Perspective

Feat. M. Davids
24:58
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on the Use of MRD in CLL: European Perspective

Feat. O. Al-Sawaf
17:57
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on CLL: Molecular and Microenvironmental Basis of I…

Feat. S. Deaglio
15:56
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Management of Infections in Patients With CLL

Feat. C. Niemann
11:57
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Debate: Do Old Prognostic Markers Still Have a Role in CLL…

Feat. I. Ahn
10:25
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Debate on Old Prognostic Markers in CLL Management: Do The…

Feat. S. Coutre
18:18
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Approaches to Therapy of Richter's Syndrome in CLL

Feat. D. Rossi
16:31
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: New Targetable Pathways in CLL

Feat. A. Danilov
08:20
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 BRUIN Trial Update on Previously Treated CLL/SLL: Pirtobru…

Feat. C. Coombs
20:46
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on the Management of Advanced CML: Blast Crisis

Feat. M. Deininger
11:04
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: How Can We Improve on AML MRD Assessment by Flow Cytometry

Feat. S. Freeman
12:54
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Menin Inhibitors in AML: What Are the Prospects?

Feat. E. Wang
09:10
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Novel Strategies to Treat Elderly With AML

Feat. T. Kadia
13:23
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Conventional Chemotherapy-Free Regimens in ALL

Feat. M. Wieduwilt
09:58
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on the Approach to Ph+ ALL: From Worst to Best?

Feat. P. Kebriaei
13:14
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Chemoresistance and Drug Profiling in ALL

Feat. B. Bornhauser
16:00
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Data on the Resistance to BCL-2i in CLL

Feat. C. Tam
11:39
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Data on the Resistance to BTKi in CLL

Feat. J. Woyach
12:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on Cellular Therapy for CLL

Feat. T. Kipps
13:01
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on the Genomically Guided Frontline Therapy in CML

Feat. T. Hughes
14:14
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Molecular Testing of CML Patients: Between Old a…

Feat. S. Soverini
13:14
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on the Approach to the Elderly Patients With AL…

Feat. S. Chiaretti
16:02
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Novel Transplant and Post-transplant Options in …

Feat. A. Logan
10:36
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Update on the Use of BCL2i in ALL: Targeting Apoptosis

Feat. W. Stock
16:31
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Familial Predisposition to AML: How Far Are We i…

Feat. L. Godley
16:28
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Beyond BCL2 Inhibition & Prospects for MCL1 Inhibitor…

Feat. M. Konopleva
11:43
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on Single Cell Profiling in AML

Feat. K. Takahashi
12:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Case Study: 1L Treatment in an Older Patient With TN-CLL W…

Feat. N. Lamanna
05:15
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Case Study: Relapse After 1L BTKi Therapy in RR-CLL Patien…

Feat. N. Lamanna
07:42
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Case Review: CLL Refractory to BTKi and to Venetoclax

Feat. J. Burke
06:17
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Case Review: Richter's Transformation of CLL to DLBCL

Feat. J. Burke
06:40
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Case Review: Optimal 1L Therapy for a Young/Fit CLL Patien…

Feat. D. Stephens
05:31
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Case Review: Optimal 1L Therapy for a Young/Fit CLL Patien…

Feat. D. Stephens
12:12
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Response and Progression in CML

Feat. J. Radich
14:59
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on the Importance of BCR-ABL Transcript Type in CML

Feat. N. Cross
13:24
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Highlights on New Drugs and New Challenges in CML

Feat. J. Cortés
14:55
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Updates on Hyper-CVAD in ALL: Lessons Learned and New Appr…

Feat. E. Jabbour
17:27
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on MRD in ALL: Techniques and Therapeutic Utility O…

Feat. L. Muffly
13:24
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Data on Novel CAR-T Constructs for ALL

Feat. P. Lu
15:27
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Updates on Asparaginase in Adults With ALL: Understanding …

Feat. I. Aldoss
15:45
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights: Novel Approaches to T-Cell ALL

Feat. D. Teachey
14:47
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Debate on the Optimal Time for Blinatumomab in ALL: Is It …

Feat. R. Rau
12:59
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Debate on the Optimal Time for CAR-T in Pediatric B-ALL: I…

Feat. R. Gardner
11:36
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Update on Childhood ALL: The Impact of Genetic Ancestry on…

Feat. S. Lee
15:33
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Update on IDH-Mutated AML: Beyond Enasidenib and Ivosideni…

Feat. C. DiNardo
15:44
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Update on FLT3-Mutated AML: Moving Towards Cure

Feat. A. Perl
12:33
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Update on Antibody-Based Therapy in AML: Immunotoxins and …

Feat. A. Fathi
15:40
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 New Horizons in TP53-Mutated AML

Feat. N. Daver
14:05
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Debate on the Maintenance Therapy in AML: Is It Necessary?

Feat. F. Ravandi
16:14
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Debate: Is Maintenance Therapy in AML Necessary?

Feat. J. Lancet
15:41
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Highlights on MRD in AML

Feat. J. Cloos
10:57
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Update on Newly Diagnosed AML: Venetoclax Combined With FL…

Feat. C. Lachowiez
08:39
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Algorithmic Diagnostic Approach and Spectrum of …

Feat. A. Ferrer
17:39
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Updates on Managing CLL Patients Relapsed or Refractory to…

Feat. J. Brown